NCT01821391 - Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses | Biotech Hunter

Enrollment

131

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

March 31, 2014

Conditions

Actinic Keratoses

Interventions

DRUG

NDL-PDT

Metvix natural daylight photodynamic therapy

DRUG

c-PDT

Metvix conventional photodynamic therapy

DRUG

placebo c-PDT

Metvix placebo conventional photodynamic therapy

Trial Locations (18)

Investigative site, Montpellier

Investigational site, Nantes

Investigational site, Nice

Investigational site, Paris

Investigative site, Rennes

Investigational site, Aachen

Investigational site, Berlin

Investigational site, Münster

Investigational site, Recklinghausen

Investigational site, Assen

Investigational site, Maastricht

Investigational site, Nijmegen

Investigational site, Huesca

Investigational site, Madrid

Investigative site, Pamplona

Investigational site, Valencia

Investigational site, Karlskoga

Investigational site, Norrköping